DIAMED medical technology

What DIAMED medical technology does

DIAMED Medizintechnik GmbH is a privately held German medical-technology company founded in 1976 in Cologne by Hans Karl Stock and currently managed by Dr. Sven Steinhoff and Joachim Seyfang after a 2014 generational transition. The company specializes in extracorporeal blood purification, distributing and co-developing therapeutic apheresis, continuous renal replacement therapy (CRRT), hemoadsorption, lipid filtration, and liver-support systems for hospitals across Germany, Austria, Switzerland, and (since 2023) the Netherlands.

Its product portfolio combines proprietary devices and trademarks (Octo Nova, the 2000 world-first multifunction device for continuous hemofiltration and therapeutic apheresis; AutoPrep, Immunapherese, Leberpherese, Rheopherese) with exclusive DACH distribution rights for partner technologies, principally the Asahi Kasei Medical Plasauto SIGMA (CRRT market leader in pediatrics), the Efferon LPS adsorber for the HematoPure Duo sepsis therapy, the VitroSorb SECORIM columns for ABO-incompatible transplantation, and (since 2023) the AW Technologies TrachFlush system for ICU ventilation. DIAMED supports this portfolio with clinical evidence generation (the Pro(a)LiFe multicentre study published in Circulation, 2013), an annual Apherese-Therapie-Seminar, and active participation in major nephrology, neurology, intensive-care, and transplantation congresses.

Revenue is generated through a sales-led, direct field-sales model selling devices, consumables (filters, adsorbers, columns), and maintenance services to maximum-care hospitals and university clinics, with consumables providing recurring pull-through on the installed base. Pricing is not publicly disclosed and the company reports no parent, no subsidiaries, no funding rounds, and no M&A activity. The customer base comprises nephrology, neurology, intensive-care, and cardiology departments within a relatively concentrated universe of German-speaking tertiary hospitals, with a 4-6 month strategic inventory of critical products maintained at a warehouse near Cologne to ensure rapid delivery.

Name

DIAMED medical technology

Legal name

DIAMED Medizintechnik GmbH

Website

https://diamed.de

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

11–50 employees

Short description

DIAMED Medizintechnik GmbH is a Cologne-based medical-technology company founded in 1976 that distributes and supports extracorporeal blood-purification systems (therapeutic apheresis, CRRT, hemoadsorption) for nephrology, neurology, intensive-care, and cardiology departments in hospitals across the DACH region and the Netherlands.

Ownership category

akta.pro rank

Headquarters

HQ city

Cologne

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Devices and Equipment Sales: DIAMED sells therapeutic apheresis and renal replacement therapy devices including the Plasauto SIGMA, Octo Nova, and accessories to hospitals and clinics in Germany, Austria, Switzerland, and the Netherlands.
2. Consumables and Adsorbers: Ongoing revenue from filters, adsorbers (LipoClear XC, tryptophan columns, SECORIM, Efferon LPS), and related consumables used in DIAMED's therapeutic apheresis and blood purification procedures.
3. Maintenance and Repair Services: DIAMED provides maintenance and repair services for its devices. Customers must perform or arrange prescribed safety inspections (STK) at specified intervals; failure to do so voids warranty claims. Services are invoiced based on actual effort using current price list rates.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

DIAMED Medizintechnik GmbH develops, manufactures, and distributes medical devices and complete therapy solutions for extracorporeal blood purification. Its portfolio covers therapeutic apheresis (lipid filtration, immunoadsorption, plasma exchange, doublefiltration plasmapheresis), hemoadsorption for sepsis, liver support, and continuous renal replacement therapy (CRRT), including the proprietary Octo Nova device and the Asahi Kasei Plasauto SIGMA system, together with proprietary consumables such as LipoClear XC filters and tryptophan/SECORIM/Efferon LPS adsorbers. The company sells these therapy solutions together with consumables, accessories, clinical training, and maintenance services to hospitals, specialist clinics, and intensive care units in Germany, Austria, Switzerland, and the Netherlands.

Differentiator

Problem solved

Functional benefit

Products and services

• Octo Nova Proprietary multifunction device for continuous hemofiltration and therapeutic apheresis used in hospitals and clinics; first device in Germany to offer automatic anticoagulation with citrate.
• Plasauto SIGMA Market-leading Japanese multifunction device for continuous renal replacement therapy (CRRT) and therapeutic apheresis, distributed by DIAMED in Germany, Austria, and Switzerland. Suitable even for the youngest and smallest paediatric patients, supports both citrate and heparin anticoagulation, and works for outpatient or inpatient use.
• LipoClear XC Optimised lipid filtration therapy procedure for lipoprotein apheresis, designed for performance, biocompatibility, sustainability, and efficiency, with reduced staff workload. Used for patients with severe lipid metabolism disorders including familial hypercholesterolaemia and elevated Lipoprotein(a).
• Tryptophan Immunoadsorption Therapeutic apheresis procedure using tryptophan-based columns to selectively remove autoantibodies for treatment of autoimmune diseases such as multiple sclerosis (MS), Myasthenia Gravis, CIDP, and NMOSD.
• SECORIM ABO Immunoadsorption Specialised plasma purification procedure using SECORIM columns (from VitroSorb AB) to specifically remove anti-A/B blood group antibodies, enabling ABO-incompatible organ transplantation.
• HematoPure Duo Innovative extracorporeal hemoadsorption procedure for intensive care and emergency medicine that combines two therapies in one adsorber. Uses the MDR-certified Efferon LPS adsorber for targeted sepsis and septic shock treatment.
• Doublefiltration Plasmapheresis (DFPP) Doublefiltration plasmapheresis therapy procedure for selective removal of plasma components, used for indications such as autoimmune and metabolic diseases.
• Liver Support Therapy Liver support (Leberpherese) extracorporeal blood purification procedure for patients with acute or chronic liver failure.
• Plasma Exchange (Plasmapheresis) Therapeutic plasma exchange (plasmapheresis) procedure used to remove and replace plasma for treating autoimmune and metabolic disorders.
• Acute Renal Replacement Therapy Continuous renal replacement therapy (CRRT) solutions for acute renal failure, delivered via DIAMED's Plasauto SIGMA and Octo Nova device platforms.
• Plasauto SIGMA Accessories Accessories and consumables for use with the Plasauto SIGMA system, supporting CRRT and therapeutic apheresis workflows.
• TrachFlush Secretion management system for invasively ventilated ICU patients, CE-marked in Europe and FDA-approved; distributed by DIAMED in Germany under the AW Technologies ApS strategic cooperation.
• Device Maintenance and Repair Services Prescribed safety inspection (STK), maintenance, and repair services for DIAMED's medical devices, invoiced based on actual effort using current price list rates.

Quantifiable outcome

• Pro(a)LiFe multicentre study published in Circulation (2013) demonstrated clinical effectiveness of lipid apheresis in patients with elevated Lipoprotein(a) and documented atherosclerosis progression.
• +2 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• AW Technologies ApS, Sundby, DenmarkflagshipStrategic or Co-development Partner · 1 January 2023Strategic cooperation announced by DIAMED for the TrachFlush secretion management system for invasively ventilated ICU patients. TrachFlush is CE-marked in Europe and has FDA approval. This partnership expands DIAMED's intensive care medicine portfolio. DIAMED is actively recruiting a nationwide sales specialist for ventilation products.
• Asahi Kasei Medical Co., Tokyo, JapancoreTechnology or Integration · 1 January 1976Long-term cooperation established at DIAMED's founding in 1976 in dialysis, therapeutic apheresis, and continuous renal replacement therapy. DIAMED distributes Asahi Kasei products including Plasauto SIGMA in Germany, Austria, and Switzerland. This partnership has continued unbroken for nearly 50 years and represents a core pillar of DIAMED's product portfolio.
• Efferon International GmbH, Tuttlingen, GermanycoreTechnology or IntegrationEfferon International GmbH supplies the MDR-certified Efferon LPS adsorber, which is a key component of DIAMED's HematoPure Duo multimodal hemoadsorption product for sepsis and septic shock treatment in intensive care and emergency medicine.
• Apherese ForschungsInstitut, Cologne, GermanycoreStrategic or Co-development PartnerLong-standing collaboration with the Apherese ForschungsInstitut for clinical research, development, and quality assurance of extracorporeal blood purification and therapeutic apheresis procedures. DIAMED supports the annual Apherese-Therapie-Seminar in Berlin organised by the institute and cooperates closely in clinical application research.
• VitroSorb AB, Malmö, SwedencoreTechnology or IntegrationVitroSorb AB is the manufacturer of the SECORIM registered trademark adsorber used in ABO immunoadsorption for ABO-incompatible organ transplantation. DIAMED distributes the SECORIM ABO immunoadsorption therapy in its markets.
• BVMed – Bundesverband Medizintechnologie e.V.minorOthersDIAMED holds a sponsoring membership in BVMed, the German Medical Technology Association.
• action medeor, Tönisvorst, GermanyminorOthersDIAMED supports the German medical aid organisation action medeor (Notapotheke der Welt / emergency pharmacy of the world), which provides medicines and medical equipment to crisis regions worldwide within 24 hours.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Customer concentration

• LinkedInlinkedin.com/company/diamed-medizintechnik-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DIAMED medical technology